Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 3/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3454265 | 0.87 | ALDH1A1 (0.36) | ALDH1A1KMT2AMEN1L3MBTL1NPSR1 | |
| SCHEMBL3454445 | 0.86 | MEN1 (0.42) | ALDH1A1KMT2AMEN1L3MBTL1NPSR1 | |
| SCHEMBL3454439 | 0.82 | ALDH1A1 (0.38) | ALDH1A1KMT2AMEN1L3MBTL1NPSR1 | |
| SCHEMBL12021013 | 0.81 | KMT2A (0.38) | ALDH1A1KMT2AMEN1L3MBTL1NPSR1 | |
| SCHEMBL12267394 | 0.81 | ALDH1A1 (0.32) | ALDH1A1KMT2AMEN1L3MBTL1NPSR1 | |
| SCHEMBL12267392 | 0.81 | ALDH1A1 (0.32) | ALDH1A1KMT2AMEN1L3MBTL1NPSR1 | |
| SCHEMBL365663 | 0.79 | SMN1; SMN2 (0.39) | ALDH1A1KMT2AMEN1L3MBTL1NPSR1 | |
| SCHEMBL9924470 | 0.79 | ALDH1A1 (0.48) | ALDH1A1KMT2AMEN1L3MBTL1NPSR1 | |
| SCHEMBL9924476 | 0.77 | ALDH1A1 (0.40) | ALDH1A1KMT2AMEN1L3MBTL1NPSR1 | |
| SCHEMBL20349638 | 0.77 | ALDH1A1 (0.54) | ALDH1A1KMT2AMEN1L3MBTL1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8420290-B2 | Acetal compounds and their preparation, polymers, resist compositions and patterning process | SHIN-ETSU CHEMICAL CO., LTD (JP) | 2013-04-16 | — | — | US | disclosed |
| US-20100136485-A1 | ACETAL COMPOUNDS AND THEIR PREPARATION, POLYMERS, RESIST COMPOSITIONS AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2010-06-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100136485-A1 | ACETAL COMPOUNDS AND THEIR PREPARATION, POLYMERS, RESIST COMPOSITIONS AND PATTERNING PROCESS | C9, ARF1, C1R | ALDH1A1 1502/4885KMT2A 496/4885MEN1 344/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.